Help | RSS Feed



Qiagen N.V. (NYSE:QGEN) Seasonal Chart

Seasonal Chart Analysis

Analysis of the Qiagen N.V. (NYSE:QGEN) seasonal charts above shows that a Buy Date of December 17 and a Sell Date of March 10 has resulted in a geometric average return of 8.13% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 14 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 11.28% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company’s sales are split almost evenly between applications in life sciences (51% of 2018 sales) and molecular diagnostics (49% of sales). Qiagen generates about 88% of its revenue from consumables and 12% from instrumentation and related services. The Americas account for the largest portion of the firm’s revenue (46%), followed by EMEA (33%) and Asia-Pacific (21%).

To download QGEN seasonal chart data, please log in or Subscribe.

 

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z


Sponsored By...
Seasonal Advantage Portfolio by CastleMoore